Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR-ABL positive K562 cells

OBJECTIVE(S): Intolerable side effects and resistance to chemotherapeutic drugs have encouraged scientists to develop new methods of drug combinations with fewer complications. This study aimed to investigate the synergistic effects of quercetin and imatinib encapsulated in chitosan nanoparticles on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamyabi, Rohollah, Jahandideh, Alireza, Panahi, Negar, Muhammadnejad, Samad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922367/
https://www.ncbi.nlm.nih.gov/pubmed/36865043
http://dx.doi.org/10.22038/IJBMS.2023.68472.14934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922367/
https://www.ncbi.nlm.nih.gov/pubmed/36865043
http://dx.doi.org/10.22038/IJBMS.2023.68472.14934

Ejemplares similares